{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:36:11Z","timestamp":1770338171092,"version":"3.49.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.iac.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T16:55:32Z","timestamp":1574355332000},"page":"25-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Subcutaneous Immunotherapy Safety"],"prefix":"10.1016","volume":"40","author":[{"given":"Mario","family":"S\u00e1nchez-Borges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Calabria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2019.09.001_bib1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2004.02.006","article-title":"Immunotherapy Committee AAAAI. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001","volume":"113","author":"Bernstein","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib2","first-page":"151","article-title":"Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience","volume":"7","author":"Ragusa","year":"1997","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib3","first-page":"52","article-title":"Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods","volume":"36","author":"Ragusa","year":"2004","journal-title":"Allerg Immunol (Paris)"},{"key":"10.1016\/j.iac.2019.09.001_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2005.10.010","article-title":"Evaluation of near-fatal reactions to allergen immunotherapy injections","volume":"117","author":"Amin","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2500\/aap.2011.32.3446","article-title":"Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine","volume":"32","author":"Phillips","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2019.09.001_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2013.01.015","article-title":"AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, year 3: what practices modify the risk of systemic reactions?","volume":"110","author":"Epstein","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.anai.2016.02.001","article-title":"Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013)","volume":"116","author":"Epstein","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/jama.1924.02650400001001","article-title":"Death associated with injection of foreign substances","volume":"82","author":"Lamson","year":"1924","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.iac.2019.09.001_bib9","series-title":"Allergens and allergy immunotherapy. Subcutaneous, sublingual and oral","first-page":"447","article-title":"Adverse effects and fatalities associated with allergen skin testing and subcutaneous allergen immunotherapy","author":"Bagg","year":"2014"},{"key":"10.1016\/j.iac.2019.09.001_bib10","first-page":"251","article-title":"Risk of inducing constitutional reactions in allergic patients","volume":"28","author":"Van Arsdel","year":"1957","journal-title":"J\u00a0Allergy"},{"key":"10.1016\/j.iac.2019.09.001_bib11","first-page":"135","article-title":"The safety of immunotherapy \u2013 A prospective study","volume":"79","author":"Hepner","year":"1987","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"82","key":"10.1016\/j.iac.2019.09.001_bib12","first-page":"147","article-title":"Hazards with desensitizing vaccines","author":"Rawlins","year":"1988","journal-title":"Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M"},{"key":"10.1016\/j.iac.2019.09.001_bib13","first-page":"364","article-title":"Physician reported patient response to immunotherapy: a retrospective study of factors affecting the response","volume":"64","author":"Rieckenberg","year":"1990","journal-title":"Ann Allergy"},{"key":"10.1016\/j.iac.2019.09.001_bib14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bmj.293.6552.948","article-title":"CSM update: desensitising vaccines","volume":"293","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.iac.2019.09.001_bib15","first-page":"1","article-title":"Incidents following hyposensitization","volume":"138","author":"L\u00fcderitz-Puchel","year":"1996","journal-title":"Munch Med Wochenschr"},{"issue":"1 Pt 1","key":"10.1016\/j.iac.2019.09.001_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0091-6749(93)90030-J","article-title":"Survey of fatalities from skin testing and immunotherapy 1985-1989","volume":"92","author":"Reid","year":"1993","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0091-6749(96)80413-1","article-title":"Deaths associated with skin testing and immunotherapy","volume":"97","author":"Reid","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaip.2013.09.017","article-title":"Improving the safety of immunotherapy","volume":"2","author":"Rank","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.001_bib19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.anai.2010.04.008","article-title":"Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study","volume":"104","author":"Bernstein","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.iac.2019.09.001_bib20","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jaip.2019.01.058","article-title":"AAAAI\/ACAAI subcutaneous immunotherapy (SCIT) surveillance study (2013-2017): fatalities, infections, delayed reactions, and use of epinephrine autoinjectors","volume":"7","author":"Epstein","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.001_bib21","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.anai.2011.06.026","article-title":"Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice","volume":"107","author":"Copenhaver","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaip.2014.01.004","article-title":"ACAAI\/AAAAI surveillance study of subcutaneous immunotherapy, years 2008-2011: an update on fatal and nonfatal systemic allergic reactions","volume":"2","author":"Epstein","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.001_bib24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.anai.2011.05.020","article-title":"Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI\/AAAAI surveillance study of subcutaneous immunotherapy: year 2","volume":"107","author":"Epstein","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/pai.12660","article-title":"The European survey on adverse systemic reactions in allergen immunotherapy (EASSI): a pediatric assessment","volume":"28","author":"Rodriguez Del Rio","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0091-6749(05)80182-4","article-title":"The Hymenoptera venom study, III, Safety of venom immunotherapy","volume":"86","author":"Lockey","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib27","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/cea.12582","article-title":"Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy","volume":"45","author":"Korosec","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.001_bib28","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0091-6749(87)80164-1","article-title":"Fatalities from immunotherapy (IT) and skin testing (ST)","volume":"79","author":"Lockey","year":"1987","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System","volume":"125","author":"Cox","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib30","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jaip.2017.03.025","article-title":"Half of systemic reactions to allergen immunotherapy are delayed, majority require treatment with epinephrine","volume":"5","author":"Cook","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.001_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2222.2006.02340.x","article-title":"Side-effects of allergen-specific immunotherapy: a prospective multi-centre study","volume":"36","author":"Winther","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.001_bib32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.anai.2016.09.005","article-title":"Comparison of systemic reactions in rush, cluster, and standard-build aeroallergen immunotherapy","volume":"117","author":"Winslow","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib33","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaci.2004.01.756","article-title":"Incorrect allergy injections: allergists' experiences and recommendations for prevention","volume":"113","author":"Aaronson","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib34","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jaci.2010.12.1086","article-title":"Factors associated with severe versus mild immunotherapy-related systemic reactions: a case-referent study","volume":"127","author":"Liss","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2500\/aap.2008.29.3142","article-title":"The need for standardizing the aeroallergen immunotherapy missed-dose adjustment protocol","volume":"29","author":"Montgomery","year":"2008","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2019.09.001_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.anai.2010.09.003","article-title":"Assessing the safety of subcutaneous immunotherapy dose adjustments","volume":"105","author":"Webber","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib38","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaip.2014.09.003","article-title":"Clinical and immunologic assessment of a cluster method during allergen immunotherapy refill dosing","volume":"2","author":"Waibel","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.001_bib39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mai.2000.110468","article-title":"Local reactions during allergen immunotherapy do not require dose adjustment","volume":"106","author":"Tankersley","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anai.2010.10.025","article-title":"The REPEAT study: recognizing and evaluating periodic local reactions in allergen immunotherapy and associated systemic reactions","volume":"106","author":"Calabria","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1081-1206(10)60626-6","article-title":"Increased frequency of large local reactions among systemic reacgtors during subcutaneous allergen immunotherapy","volume":"99","author":"Roy","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0091-6749(95)70146-X","article-title":"Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions","volume":"95","author":"Tinkelman","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib43","first-page":"557","article-title":"Nonfatal systemic allergic reactions induced by skin testing and immunotherapy","volume":"71","author":"Lin","year":"1993","journal-title":"Ann Allergy"},{"issue":"5","key":"10.1016\/j.iac.2019.09.001_bib44","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jaip.2017.03.021","article-title":"Systemic reactions to immunotherapy during mountain cedar season: implications for seasonal dose adjustment","volume":"5","author":"Wong","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.001_bib45","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jaip.2017.11.040","article-title":"Systemic reactions in pediatric patients receiving standardized allergen subcutaneous immunotherapy with and without seasonal dose adjustment","volume":"6","author":"Albuhairi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.001_bib46","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaip.2016.05.014","article-title":"Coseasonal initiation of allergen immunotherapy: a systematic review","volume":"4","author":"Creticos","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.001_bib47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.anai.2011.02.007","article-title":"Systemic reactions associated with subcutaneous allergen immunotherapy: timing and risk assessment","volume":"106","author":"DaVeiga","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib48","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1081-1206(10)63556-9","article-title":"Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis","volume":"96","author":"Ohashi","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib49","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0091-6749(96)70186-0","article-title":"Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study","volume":"97","author":"Neilsen","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mai.2003.41","article-title":"A\u00a0double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract","volume":"111","author":"Ewbank","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1067\/mai.2001.112027","article-title":"Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial","volume":"107","author":"Walker","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib52","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0091-6749(90)90157-Y","article-title":"Immuntoherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule","volume":"85","author":"Heijaioui","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib53","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0091-6749(92)90214-M","article-title":"Systemic reactions occurring during immunotherapy with standardized pollen extracts","volume":"89","author":"Heijaioui","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib54","first-page":"493","article-title":"Incidence of systemic reactions during rush immunotherapy","volume":"68","author":"Portnoy","year":"1992","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib55","first-page":"409","article-title":"Premedication reduces the indicence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts","volume":"73","author":"Portnoy","year":"1994","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1081-1206(10)63419-9","article-title":"Rush immunotherapy: experience with a one-day schedule","volume":"76","author":"Sharkey","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib57","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S1081-1206(10)61776-0","article-title":"Safety of rush immunotherapy to multiple aeroallergens in an adult population","volume":"92","author":"Harvey","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib58","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.jaip.2017.04.015","article-title":"Increased risk of systemic reactions extends beyond completion of rush immunotherapy","volume":"5","author":"Cook","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.001_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0091-6749(98)70190-3","article-title":"Epinephrine absorption in children with a history of anaphylaxis","volume":"101","author":"Simons","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib60","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1067\/mai.2001.119409","article-title":"Epinephrine absorption in adults: intramuscular versus subcutaneous injection","volume":"108","author":"Simons","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.anai.2015.11.009","article-title":"Experience with epinephrine delivery in\u00a0immunotherapy-associated systemic reactions","volume":"116","author":"Wong","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2019.09.001_bib62","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1710-1492-7-S1-S6","article-title":"Anaphylaxis","volume":"7","author":"Kim","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib63","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jaci.2009.08.025","article-title":"Anaphylaxis: recent advances in assessment and treatment","volume":"124","author":"Simons","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib64","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jaci.2008.10.026","article-title":"Incidence and chaaracteristics of biphasic reactions after allergen immunotherapy","volume":"123","author":"Scranton S Gonzalez","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.anai.2009.11.001","article-title":"Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study","volume":"104","author":"Confino Cohen","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.001_bib66","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jaip.2016.04.007","article-title":"Should epinephrine autoinjectors be prescribed to all patients on subcutaneous immunotherapy?","volume":"4","author":"Fitzhugh","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:43:34Z","timestamp":1760179414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856119300633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0889856119300633"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous Immunotherapy Safety","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}